FR2435905A1
(fr)
*
|
1978-09-13 |
1980-04-11 |
Anvar |
Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
|
US4315018A
(en)
*
|
1978-12-07 |
1982-02-09 |
Rossignol Jean F |
Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
|
IT1144025B
(it)
*
|
1979-12-21 |
1986-10-29 |
Wellcome Found |
Derivati nitrotiazolinici e relativo procedimento di produzione
|
US5387598A
(en)
*
|
1994-04-13 |
1995-02-07 |
Rossignol; Jean-Francois |
Composition and galenic formulation suitable for combatting affections of the lower abdomen
|
CZ287002B6
(en)
*
|
1994-04-13 |
2000-08-16 |
Rossignol Jean Franaois |
Benzamide derivative, pharmaceutical preparation containing thereof and use of the derivative
|
US5578621A
(en)
*
|
1994-09-08 |
1996-11-26 |
Romark Lab Lc |
Benzamide derivatives
|
US5968961A
(en)
*
|
1997-05-07 |
1999-10-19 |
Romark Laboratories, L.C. |
Pharmaceutical compositions of tizoxanide and nitazoxanide
|
US5859038A
(en)
*
|
1994-09-08 |
1999-01-12 |
Romark Laboratories, L.C. |
Method for treatment of helicobacter pylori infections
|
MX9604483A
(es)
*
|
1994-09-08 |
1998-02-28 |
Jean-Francois Rossignol |
Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
|
AU756451B2
(en)
*
|
1997-05-07 |
2003-01-16 |
Romark Laboratories, L.C. |
Pharmaceutical compositions of tizoxanide and nitazoxanide
|
DK1222921T3
(da)
*
|
1997-05-07 |
2005-03-07 |
Romark Lab Lc |
Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid
|
US5935591A
(en)
*
|
1998-01-15 |
1999-08-10 |
Romark Laboratories, L.C. |
Method for treatment of equine protozoal myeloencephalitis with thiazolides
|
US5925622A
(en)
*
|
1998-07-13 |
1999-07-20 |
Romark Laboratories, L.C. |
Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
GB0226930D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0325402D0
(en)
*
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
GB0327761D0
(en)
*
|
2003-11-29 |
2003-12-31 |
Astrazeneca Ab |
Compounds
|
GB0328178D0
(en)
*
|
2003-12-05 |
2004-01-07 |
Astrazeneca Ab |
Compounds
|
EP1718625A1
(fr)
*
|
2004-02-18 |
2006-11-08 |
AstraZeneca AB |
Composes
|
DE602005013491D1
(de)
*
|
2004-02-18 |
2009-05-07 |
Astrazeneca Ab |
Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
|
TW200600086A
(en)
*
|
2004-06-05 |
2006-01-01 |
Astrazeneca Ab |
Chemical compound
|
UA90864C2
(en)
*
|
2004-09-09 |
2010-06-10 |
Ромарк Лебораториз, Л.К. |
Halogenated benzamide derivatives
|
US20060194853A1
(en)
*
|
2004-10-08 |
2006-08-31 |
Rossignol Jean F |
Alkyl benzamides
|
KR20070085371A
(ko)
|
2004-10-16 |
2007-08-27 |
아스트라제네카 아베 |
페녹시 벤즈아미드 화합물의 제조 방법
|
GB0423044D0
(en)
*
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
GB0423043D0
(en)
*
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
US20070015803A1
(en)
*
|
2005-04-12 |
2007-01-18 |
Romark Laboratories L.C. |
Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
|
EP1891069A1
(fr)
*
|
2005-05-24 |
2008-02-27 |
AstraZeneca AB |
Derives d'imidazol[4,5b]pyridine/pyrazine et purine substitues en 2-phenyl en tant que modulateurs de la glucokinase
|
TW200714597A
(en)
*
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
EP2027113A1
(fr)
*
|
2005-07-09 |
2009-02-25 |
AstraZeneca AB |
Dérivés d'hétéroaryl benzamide utilisés en tant qu'activateurs de la glk dans le traitement du diabète
|
BRPI0622261A2
(pt)
*
|
2005-07-09 |
2011-08-09 |
Astrazeneca Ab |
composto, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
|
US20110053910A1
(en)
*
|
2005-07-09 |
2011-03-03 |
Mckerrecher Darren |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
US9202182B2
(en)
*
|
2005-08-11 |
2015-12-01 |
International Business Machines Corporation |
Method and system for analyzing business architecture
|
TW200738621A
(en)
*
|
2005-11-28 |
2007-10-16 |
Astrazeneca Ab |
Chemical process
|
EP1976516B9
(fr)
|
2006-01-09 |
2013-10-30 |
Romark Laboratories, L.C. |
Traitement de l'hépatite virale
|
US7678791B2
(en)
*
|
2006-07-12 |
2010-03-16 |
Cumbre Ip Ventures, L.P. |
Nitroheteroaryl-containing rifamycin derivatives
|
CN100465169C
(zh)
*
|
2006-08-02 |
2009-03-04 |
杭州欣阳三友精细化工有限公司 |
硝唑尼特的制备方法
|
TW200825063A
(en)
*
|
2006-10-23 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
TW200825060A
(en)
*
|
2006-10-26 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
US20100094009A1
(en)
*
|
2006-12-21 |
2010-04-15 |
Mccabe James |
Novel crystalline compound useful as glk activator
|
CN101007792B
(zh)
*
|
2007-01-31 |
2010-05-26 |
浙江大学 |
一种合成硝基噻唑苯酰胺化合物的方法
|
MX2010001358A
(es)
|
2007-08-03 |
2010-04-09 |
Romark Lab Lc |
Compuestos de tiazolida sustituidos con alquilsulfonilo.
|
MX2011001333A
(es)
*
|
2008-08-04 |
2011-03-15 |
Astrazeneca Ab |
Derivados de pirazolo [3, 4] pirimidin-4-ilo y sus usos para tratar la diabetes y obesidad.
|
CN102272134B
(zh)
|
2008-12-09 |
2013-10-16 |
吉里德科学公司 |
Toll样受体调节剂
|
GB0902434D0
(en)
*
|
2009-02-13 |
2009-04-01 |
Astrazeneca Ab |
Chemical process
|
LT2395840T
(lt)
|
2009-02-13 |
2020-07-10 |
Romark Laboratories, L.C. |
Nitazoksanido kontroliuojamo atpalaidavimo farmacinės kompozicijos
|
GB0902406D0
(en)
*
|
2009-02-13 |
2009-04-01 |
Astrazeneca Ab |
Crystalline polymorphic form
|
WO2010116176A1
(fr)
*
|
2009-04-09 |
2010-10-14 |
Astrazeneca Ab |
Dérivé de pyrazolo [4, 5-e] pyrimidine et son utilisation pour traiter le diabète et l'obésité
|
WO2010116177A1
(fr)
|
2009-04-09 |
2010-10-14 |
Astrazeneca Ab |
Dérivé de pyrazolo [4,5-e] pyrimidine et son utilisation pour traiter le diabète et l'obésité
|
CA2761876C
(fr)
|
2009-05-12 |
2017-01-03 |
Romark Laboratories L.C. |
Composes haloalkyl heteroaryl benzamide
|
KR20170141830A
(ko)
*
|
2009-06-26 |
2017-12-26 |
로마크 레버러토리즈, 엘.씨. |
인플루엔자를 치료하기 위한 화합물 및 방법
|
CN101602744B
(zh)
*
|
2009-06-30 |
2011-06-01 |
青岛康地恩药业有限公司 |
一种硝唑尼特的制备方法
|
BR112014018149B1
(pt)
|
2012-01-27 |
2020-09-29 |
Siegfried Rhein S.A. De C.V |
Composição farmacêutica de nitazoxanida
|
MX340272B
(es)
|
2012-09-27 |
2016-06-30 |
Rhein Siegfried Sa De Cv |
Composicion sinergica de nitazoxanida y mebendazol, procesos para prepararla y el uso de dicha composicion para el tratamiento de la parasitosis humana.
|
US20160244435A1
(en)
*
|
2013-06-21 |
2016-08-25 |
The Scripps Research Institute |
Expanded therapeutic potential in nitroheteroaryl antimicrobials
|
KR20190104438A
(ko)
|
2014-07-11 |
2019-09-09 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv의 치료를 위한 톨-유사 수용체의 조정제
|
EA201790369A1
(ru)
|
2014-09-16 |
2017-10-31 |
Джилид Сайэнс, Инк. |
Твердые формы модулятора толл-подобного рецептора
|
CN107105660A
(zh)
|
2014-11-11 |
2017-08-29 |
罗马克实验室有限公司 |
使用替唑尼特、其类似物或盐的前药的治疗组合物和治疗方法
|
CN105175352A
(zh)
*
|
2015-10-27 |
2015-12-23 |
杭州澳医保灵药业有限公司 |
一种硝唑尼特的制备方法
|
CN106831640A
(zh)
*
|
2015-12-03 |
2017-06-13 |
江苏正大丰海制药有限公司 |
一种硝唑尼特晶体的制备方法
|
PL3436074T3
(pl)
|
2016-03-31 |
2020-11-02 |
Romark Laboratories, L.C. |
Związki z grupą tiazolidynową do leczenia zakażeń wirusowych
|
US20170290812A1
(en)
|
2016-04-11 |
2017-10-12 |
Genfit |
Methods of treatment for cholestatic and fibrotic diseases
|
EP3573614A1
(fr)
|
2017-01-27 |
2019-12-04 |
Genfit |
Compositions pharmaceutiques pour polythérapie
|
WO2018195035A1
(fr)
|
2017-04-18 |
2018-10-25 |
Romark Laboratories L.C. |
Inhibition de la protéine disulfure-isomérase a3
|
WO2020208208A1
(fr)
|
2019-04-12 |
2020-10-15 |
Genfit |
Nitazoxanide et thiazolides destinés à être utilisés dans le traitement de maladies associées au stress oxydatif
|
CN114630660A
(zh)
|
2019-10-28 |
2022-06-14 |
基恩菲特公司 |
具有抗氧化特性的联合疗法
|
CA3186666A1
(fr)
|
2020-07-20 |
2022-01-27 |
Jean-Francois Rossignol |
Sels cristallins de tizoxanide et de 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) avec de l'ethanolamine, de la morpholine, de la propanolamine, de la piperazine et de la n-methylpiperazin
|
AU2021333566A1
(en)
|
2020-08-24 |
2023-03-16 |
Romark Laboratories L.C. |
Use of thiazolides against coronaviruses
|
CN114044761B
(zh)
*
|
2021-02-24 |
2022-05-17 |
成都贝诺科成生物科技有限公司 |
一种新的硝基噻唑衍生物及其应用
|
CN115197164A
(zh)
*
|
2021-04-12 |
2022-10-18 |
杜心赟 |
新型噻唑类化合物及其制备方法和用途
|
CN116898846A
(zh)
*
|
2022-04-12 |
2023-10-20 |
成都贝诺科成生物科技有限公司 |
一种硝基噻唑衍生物在制备抑制幽门螺杆菌的抑菌剂中的用途
|